Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK

BMC Cardiovascular Disorders

Volumn 5, Issue , 2005, Pages

  Ruigómez, Ana ^a   Johansson, Saga ^b,c   Wallander, Mari Ann ^b,d   García Rodríguez, Luis Alberto ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GENERAL PRACTICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTHYROIDISM; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; UNITED KINGDOM; VALVULAR HEART DISEASE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DRINKING BEHAVIOR; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; HYPERTHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 26944493432     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-5-20     Document Type: Article

References (25)

1. Aboaf AP, Wolf PS. Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med 1996;156:362-7.
2. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:1231-66.
3. Lévy S. Classification system of atrial fibrillation. Curr Opin Cardiol 2000;15:54-7.
4. Lip GYH, Hee FL. Paroxysmal atrial fibrillation. QJM 2001;94:665-78.
5. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-7.
6. Kaufman ES, Waldo AL. The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 2004;43:47-52.
7. Lévy S, Breithardt G, Campbell RWF, Camm AJ, Daubert JC, Allessie M, Aliot E, Capucci A, Cosio F, Crijns H, Jordaens L, Hauer RN, Lombardi F, Luderitz B. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998;19:1294-320.
8. Lévy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 1998,9:S78-82.
9. Petersen P. Thromboembolic complications of atrial fibrillation and their prevention: a review. Am J Cardiol 1990;65:24C-8C.
10. Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. The incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002; 55:358-63.
11. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-26.
12. Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord 2002;2:5.
13. Goudevenos JA, Vakalis JN, Giogiakas V, Lathridou P, Katsouras C, Michalis LK, Sideris DA. An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece. Europace 1999;1:226-33.
14. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997;314:1529-30.
15. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18):2370-5.
16. Lévy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A, for the College of French Cardiologists. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999; 99:3028-35.
17. Johansson S, Wallander MA, García Rodríguez LA, Ruigómez A. Permanent and paroxysmal atrial fibrillation in general practice. Pharmacoepidemiol Drug Saf 2003;12:S-109.
18. Scardi S, Mazzone C, Pandullo C, Goldstein D, Poletti A, Humar F. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J. 1999;137: 686-91.
19. Gersh BJ, Solomon A. Lone atrial fibrillation: Epidemiology and natural history. Am Heart J 1999;137:592-5
20. Domanski MJ. The epidemiology of atrial fibrillation. Coron Artery Dis 1995;6:95-100.
21. Lip GYH, Hart RG, Conway DSG. Antithrombotic therapy for atrial fibrillation. BMJ 2002;325:1022-5.
22. Inoue H, Atarashi H, for the Research Group for Antiarrhythmic Drug Therapy. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation. Am J Cardiol 2000;86:852-5.
23. Abe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K, Kim J, Sanada S, Hori M, Hoki N. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation 1997;96:2612-6.
24. Sakamoto H, Kurabayashi M, Nagai R,Fujii J. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation. Circulation 1998,98:1045-6.
25. Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrilaltion-Observations from a 14-year follow-up study-. Circ J 2004 ;68 :568-572.